Clinical Trials Browser

Phase 3 × OTHER × Celecoxib × Clear all

NCT01150045 2026-05-19

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Phase 3 Completed

2,527 enrolled 14 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT04176419 2024-11-12

Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery

Phase 3 Terminated

Head and Neck Neoplasms

NCT06545526 2024-08-09

Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis

Phase 3 Recruiting

Gastrointestinal

Adenomatous Polyposis Coli

NCT05327751 2022-04-14

HFS

Phase 3 Unknown

Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

NCT02429427 2020-06-23

REACT

Phase 3 Completed

2,639 enrolled 12 charts

Breast Neoplasms

NCT02108366 2019-10-21

Treatment of Severe Influenza A Infection

Phase 3 Completed

Influenza, Human, Lymphoma, Follicular

NCT03059238 2019-08-13

Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure

Phase 3 Completed

Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

NCT03184493 2019-05-31

XBD

Phase 3 Unknown

Gastrointestinal

Liver Neoplasms

NCT01041781 2018-07-23

Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 3 Terminated

313 enrolled 14 charts

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00305643 2015-12-24

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Phase 3 Terminated

11 enrolled 7 charts

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

NCT02537925 2015-09-02

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma

Phase 3 Unknown

Nasopharyngeal Carcinoma

NCT00981201 2012-08-01

Celecoxib as a Chemopreventive Agent in Current and Former Smokers

Phase 3 Completed

Smoking

NCT00525096 2011-06-30

Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT00300729 2009-06-30

CYCLUS

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00603759 2008-01-29

COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma

Phase 3 Unknown

Head and Neck Neoplasms

NCT00211952 2005-09-21

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

Phase 3 Suspended

Carcinoma, Non-Small-Cell Lung